Friis Petersen, Jesper <br/><br/>
Soluble urokinase plasminogen activator receptor (suPAR) as a biomarker of early pregnancy location and viability compared with hCG, progesterone and estradiol.  [electronic resource] 

 -  Journal of reproductive immunology  04 2020 
 - 103103 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1872-7603 
<br/><br/><label>Standard No.: </label>10.1016/j.jri.2020.103103  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Abortion, Spontaneous--blood<br/>Adult<br/>Biomarkers--blood<br/>Case-Control Studies<br/>Chorionic Gonadotropin--blood<br/>Denmark--epidemiology<br/>Estradiol--blood<br/>Feasibility Studies<br/>Female<br/>Humans<br/>Inflammation--blood<br/>Live Birth<br/>Predictive Value of Tests<br/>Pregnancy<br/>Pregnancy Outcome<br/>Pregnancy Trimester, First<br/>Pregnancy, Ectopic--blood<br/>Progesterone--blood<br/>Prospective Studies<br/>ROC Curve<br/>Receptors, Urokinase Plasminogen Activator--blood<br/>Risk Assessment--methods<br/>Young Adult